Schedule 13D ownership disclosure

PIERIS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 720795103

Event date: 2015-06-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
18.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000905718-15-000590
Form type
SC 13D
Filer
ORBIMED ADVISORS LLC
CIK
CIK 1055951
Filed
Jul 09, 2015
Reporting period
Jun 29, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub